| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.44B | +3.3% |
| Cost of Revenue | $6.80B | +2.0% |
| Gross Profit | $8.64B | +4.3% |
| R&D Expense | $399.0M | +6.4% |
| SG&A Expense | $6.14B | +9.0% |
| Operating Income | $2.51B | -6.1% |
| Interest Expense | $250.0M | — |
| Pre-tax Income | $2.19B | -17.0% |
| Income Tax | $526.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.38B | +12.3% |
| Accounts Receivable | $2.07B | -2.3% |
| Inventory | $1.85B | -16.8% |
| Current Assets | $6.14B | +4.4% |
| Total Assets | $27.85B | +2.0% |
| Current Liabilities | $5.48B | +39.6% |
| Long-term Debt | $7.69B | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.17B | +25.5% |
| Capital Expenditures | $469.0M | +25.1% |
| Investing Cash Flow | -$488.0M | -25.1% |
| Financing Cash Flow | -$2.53B | -59.6% |
| Free Cash Flow | $2.70B | +25.5% |
| -8.2% |
| Net Income | $1.66B | -19.4% |
| EPS (Basic) | $0.90 | -25.0% |
| EPS (Diluted) | $0.90 | -25.0% |
| Total Liabilities |
| $16.64B |
| +128.1% |
| Stockholders' Equity | $11.21B | -44.0% |